42 U.S.C. § 247b–15 — Surveillance and education regarding infections associated with illicit drug use and other risk factors

(a) In general The Secretary, through the Director of the Centers for Disease Control and Prevention, may fund programs — directly or through grants to public and nonprofit private entities — to: (1) work with states and Indian tribes to build or maintain a national system tracking how common infections linked to illicit drug use are, such as viral hepatitis, HIV, and infective endocarditis, and help states figure out how widespread these infections are, which can include reporting cases; (2) identify, counsel, and offer testing to people at risk of these infections because of illicit drug use, blood transfusions received before July 1992, or other risk factors; (3) refer people identified in (2) for appropriate counseling, testing, and medical treatment, and, as much as practical, make sure they get follow-up services; (4) create and share public information and education programs to detect and control these infections, prioritizing whatever high-risk populations the Secretary identifies; and (5) improve health professionals' education, training, and skills in detecting and controlling these infections, including better coordination between substance use disorder treatment and infectious disease care, prioritizing substance use disorder providers, pediatricians and other primary care providers, obstetrician-gynecologists, and infectious disease clinicians, including HIV clinicians. (b) Laboratory procedures The Secretary may fund programs, directly or through grants to public and nonprofit private entities, to improve the quality of clinical lab procedures for these infections. (c) Definition In this section, "Indian tribe" means what section 5304 of title 25 says. (d) Authorization of appropriations $40,000,000 is authorized for each of fiscal years 2026 through 2030.